Several studies have shown that breast cancer with Ki-67 expression more than 20–50% has a high risk of metastases, indicating that there are statistically significant correlations with clinical outcomes, such as disease-free survival and overall survival [10,11]. The gene discussed is MKI67; the disease is breast cancer.